Influenza vaccine effectiveness
Vaccine effectiveness is an estimate of the likelihood that a vaccine prevents influenza infection when used in everyday practice. To establish how well influenza vaccines work each season, influenza vaccine effectiveness is measured in observational studies. Vaccine effectiveness is an estimate of the likelihood that a vaccine prevents influenza infection when used in everyday practice.
Public health guidance: Seasonal influenza vaccination of children and pregnant women
The aim of this guidance document is to provide EU/EEA Member States and EU bodies with relevant information to make an informed decision on routine vaccination of healthy children and pregnant women with seasonal influenza vaccine. The options presented in this document are based on a systematic review of the literature and the opinions of a group of independent experts.
Expert opinion on rotavirus vaccination in infancy
ECDC has published an Expert Opinion on rotavirus vaccination in infancy. The paper provides EU/EEA Member States with relevant scientific information on burden of rotavirus disease, vaccine effectiveness and safety, and cost-effectiveness studies to support the decision-making process on the possible introduction of routine vaccination of children against rotavirus gastroenteritis.
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
Kissling, E., Pozo, F., Buda, S., Vilcu, A.-M., Rizzo, C., Gherasim, A., Horváth, J.K., Brytting, M., Domegan, L., Meijer, A., Paradowska-Stankiewicz, I., Machado, A., Vučina, V.V., Lazar, M., Johansen, K., Dürrwald, R., van der Werf, S., Bella, A., Larrauri, A., Ferenczi, A., Zakikhany, K., O'Donnell, J., Dijkstra, F., Bogusz, J., Guiomar, R., Filipović, S.K., Pitigoi, D., Penttinen, P., Valenciano, M.
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort
Kissling, E., Pozo, F., Buda, S., Vilcu, A.-M., Gherasim, A., Brytting, M., Domegan, L., Gómez, V., Meijer, A., Lazar, M., Vučina, V.V., Dürrwald, R., van der Werf, S., Larrauri, A., Enkirch, T., O'Donnell, J., Guiomar, R., Hooiveld, M., Petrović, G., Stoian, E., Penttinen, P., Valenciano, M., I-Move Primary Care Study Team
Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for 2012–13
This report provides an update on seasonal influenza immunisation policies and vaccination coverage rates in EU/EEA Member States for the 2012–13 influenza season.
Seasonal influenza vaccination in Europe – Vaccination recommendations and coverage rates for 2013-14 and 2014-15
Overview of vaccination recommendations and coverage rates in the EU Member States for the 2013–14 and 2014–15 influenza seasons.
Effect of introducing high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children
This is the main finding of a recent article based on data from The Streptococcus pneumoniae Invasive Disease network (SpIDnet).